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Background: Alpinia oxyphylla is a common remedy in traditional Chinese medicine. Yakuchinone A is a major
constituent of A. oxyphylla and exhibits anti-inflammatory, antitumor, antibacterial, and gastric protective activities.
Methods: Antioxidant and antitumor characteristics of yakuchinone A in skin cancer cells as well as novel
mechanisms for the inhibition of adipocyte differentiation, cestocidal activities against Hymenolepis nana adults, and
nematocidal activities against Anisakis simplex larvae are investigated.
Results: Yakuchinone A presents the ability of the removal of DPPH·and ABTS+ free radicals and inhibition of lipid
peroxidation. Yakuchinone A suppresses intracellular lipid accumulation during adipocyte differentiation in 3 T3-L1 cells
and the expressions of leptin and peroxisome proliferator-activated receptor γ (PPARγ). Yakuchinone A induces apoptosis
and inhibits cell proliferation in skin cancer cells. The inhibition of cell growth by yakuchinone A is more significant for
non-melanoma skin cancer (NMSC) cells than for melanoma (A375 and B16) and noncancerous (HaCaT and BNLCL2) cells.
Treatment BCC cells with yakuchinone A shows down-regulation of Bcl-2, up-regulation of Bax, and an increase in
cleavage poly (ADP-ribose) polymerase (PARP). This suggests that yakuchinone A induces BCC cells apoptosis through the
Bcl-2-mediated signaling pathway. The anthelmintic activities of yakuchinone A for A. simplex are better than for H. nana.
Conclusions: In this work, yakuchinone A exhibits antioxidative properties, anti-adipocyte differentiation, antitumor
activity, and anthelmintic activities against A. simplex and H. nana.
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Free radicals include superoxide anion (O2
-), hydroxyl
(HO·), peroxyl (ROO·), alkoxyl (RO·) and nitric oxide,
which are oxygen-centered free radicals occasionally
known as reactive oxygen species (ROS). Cellular oxida-
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reproduction in any medium, provided the orestablished general mechanism for cell as well as tissue
injury [1,2]. ROS are strongly associated with lipid per-
oxidation, which leads to the deterioration of the food,
and are also involved in a variety of diseases including
cellar aging, mutagenesis, carcinogenesis, coronary heart
disease, diabetes mellitus, and neurodegeneration [2].
Obesity has become a global health problem due to its
association with various metabolic disorders such as
type-II diabetes, cardiovascular disease, hypertension,
and non-alcoholic fatty liver disease [3,4]. Synthetic anti-
obesity drugs have been reported to be costly, and some
of them also beset with undesirable side effects. There-
fore, developing drugs to directly modulate energy. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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has caused substantial attention [4,5].
Natural/herbal compounds including berberine, resvera-
trol, and curcumin are known to modulate obesity either
through increasing energy expenditure or inhibiting adi-
pocyte differentiation [6-8]. Presently the focus is to de-
velop natural compounds as antioxidants that are possibly
used to reduce damage caused by oxidative stress, age-
dependent diseases, and obesity [9].
Hymenolepis nana is a general occasion of cestode in-
fections, and is found worldwide. In human adults, the
tapeworm is more of a nuisance than a health problem,
but in small children, H. nana is dangerous. It is often
seen in children in countries with inadequate sanitation
and hygiene. H. nana infections are typically asymptom-
atic but heavy infections also cause headaches, anorexia,
weakness, abdominal pain, and diarrhea [10]. H. nana is
the only cestode without any intermediate hosts in its
life cycle [11]. H. nana infection is typically acquired
from eggs in the feces from another infected individual,
which are transferred by contaminated food. Eggs hatch
in the duodenum, releasing oncospheres that penetrate
the mucosa and enter the lymph channels of the villi.
Then, oncospheres develop into a cysticercoid, which
has a tail and a well formed scolex. About five to six
days cysticercoids migrate into the lumen of the small
intestine and attach before maturing. Eggs of H. nana
infect when passed with stool and transfer in contami-
nated food. Eggs are ingested by an arthropod inter-
mediate host and hatch in the duodenum, releasing
oncospheres, and develop into cysticercoid larvae. Upon
rupture of the villus, the cysticercoids return to the in-
testinal lumen, evaginate their scoleces, attach to the
intestinal mucosa, and mature into adults that reside
in the ileal portion of the small intestine, producing
gravid proglottids. The eggs are then passed in stools
when released from the proglottids or disintegration of
proglottids in the small intestine. An alternate mode of
infection consists of internal autoinfection without
passing through the external environment. The short
life span and rapid course of development also facili-
tates the spread and ready availability of this worm,
but internal autoinfection allows the infection to con-
tinue for years [11,12].
Anisakis simplex adult worms mature and release eggs
from the primary host. The eggs pass from stool into
seawater and are embryonated to form A. simplex first-
stage larvae (AsL1) and subsequently moulted to A. simplex
second-stage larvae (AsL2). When larvae are ingested by
small crustacean first intermediate hosts, the AsL2 matures
into A. simplex third-stage larvae (AsL3) that are subse-
quently consumed by second intermediate hosts such as
marine fish or squid. The AsL3 migrate into the viscera
and peritoneal cavity. The degree of migration into the fishmusculature depends on environmental conditions and/or
the species of parasite and fish condition [13,14]. AsL3 are
repeatedly transferred between fish and fish through the
food chain. Therefore, piscivorous fish accumulate large
numbers of AsL3 [14]. Finally, the ingestion of infected
fish or squid by a marine mammal (i.e. the final host)
leads to the development of fourth-stage larvae and
then adults. Humans may be accidental hosts by con-
suming undercooked and/or raw second intermediate
hosts that contain AsL3. A. simplex rarely develop fur-
ther within the human gastrointestinal tract, instead,
by means of proteolytic enzymes, but they typically
embed in the gastric or intestinal mucosa and die or
invasion the muscular layers of the stomach and intes-
tine to induce allergic reactions and a variety of ab-
dominal symptoms that are characterized as anisakiasis
or anisakidosis [15]. The four main clinical syndromes
in humans who experience symptomatic anisakidosis
include gastric, intestinal, extra-gastrointestinal, and
allergic diseases. Anisakidosis is globally recognized as
a public health problem, which is relative to Asia and
Europe [16,17]. The prevalence of anisakidosis has in-
creased unusually because of the increasing popularity of
Japanese cuisine, such as “sushi” and “sashimi”. The avail-
ability of an anthelmintic compound against A. simplex
has the potential to shorten the clinical course and pre-
vent mechanical invasion that cause from endoscopic pro-
cedures. Because few effective studies for anthelmintic
drugs and nature compounds against A. simplex, the ef-
fectiveness of treatment with anthelmintic agents, anti-
biotics, anticholinergics, and/or corticosteroids against
A. simplex remains controversial [18].
Alpinia oxyphylla is an important traditional Chinese
medicinal herb whose fruits are widely used as a tonic,
aphrodisiac, anti-salivation, anti-polyuria, and anti-
diarrhea [19]. The extracts from A. oxyphylla possess
neuroprotective activity, anti-tumor, anti-anaphylactic,
and inhibition of nitric oxide production [19,20].
Yakuchinone A [1-(4′-hydroxy-3′-methoxyphenyl)-7-
phenyl-3-heptanone], a major pungent ingredient de-
rived from A. oxyphylla exhibits anti-inflammatory,
antitumor, antibacterial, antiviral, and gastric protective ac-
tivities [21]. Yakuchinone A has been reported to be a
strong inhibitor of prostaglandin biosynthesis in vitro [22].
Moreover, yakuchinone A can act as an anti-tumor pro-
moter as determined by the ability to suppress phorbol
ester-induced activation of ornithine decarboxylase (ODC)
and inhibits the promotion of papilloma formation in
mouse skin [23]. 12-O-tetradecanoylphorbol-13-acetate
(TPA)-stimulated superoxide generation and tumor necro-
sis factor-α (TNF-α) or interleukin-1α production in hu-
man promyelocytic leukemia (HL-60) cells as well as on
DNA binding of activator protein 1 (AP-1) in mouse fibro-
blast (NIH3T3) cells are also suppressed by yakuchinone A
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death in HL-60 cells account for the antiproliferative activ-
ity [23]. However, the biochemical mechanisms underlying
the antioxidant, anti-obesity, anti-skin cancer effects of
yakuchinone A and its cestocidal effects on H. nana and
larvicidal effects on A. simplex remain unclear. This
study confirms the antioxidant and antitumor effects
of yakuchinone A and elucidates the novel mechanisms
for its inhibition of adipocyte differentiation as well as its




ethylbenzothiazoline-6-sulfonic acid) diammonium salt
(ABTS•+), 2,5,7,8-tetramethylchroman carboxylic acid
(trolox), trichloracetic acid (TCA), 2-thiobarbituric acid
(TBA) and 3-isobutyl-1-methylxanthine (IBMX) were pur-
chased form Sigma Chemical Co. (Sigma, St. Louis, MO).
Extraction and isolation
The “Yizhiren”, A. oxyphylla, was supplied from Kwong-
Te Co., Kaohsiung, Taiwan and was identified by profes-
sor Hang-Ching Lin of the National Defense Medicinal
Center, where a voucher specimen was deposited (CNUPS
No.970801). The dry powder of A. oxyphylla seed (6.0 kg)
was extracted with 95% ethanol at room temperature.
After removal of the solvent by evaporation, the residue
(559.0 g) was dissolved in methanol–water (9.5:0.5) and
partitioned with n-hexane. The methanol (95%) was
removed by evaporation and the residue was then
suspended in water and partitioned with ethyl acetate
(359.0 g). The ethyl acetate layer was subjected to LH-
20 Sephadex and eluted with methanol. Each fraction
collected from the column was monitored by thin-layer
chromatography and the similar fractions were combined
to produce 4 fractions. The fraction 3 was further purified
by a silica gel and eluted with n-hexane-ethyl acetate (9:1,
7.5:2.5, 1:1, 2.5:7.5), ethyl acetate, ethyl acetate-methanol
(9:1), methanol to isolate yakuchinone A (276.1 mg). Their
structures were confirmed by NMR and mass spectra
analysis.
Yakuchinone A: slightly yellow oil; EI/MS m/z (rel.
int.%): 312(80, [M]+), 194 (6), 179 (45), 161 (14), 151
(33), 137 (100), 119 (23); 1H-NMR (CDCl3, 500 MHz)
δ: 1.60 (4H, m, H-5,6), 2.40 (2H, t, J =7.0 Hz, H-4),
2.60 (2H, t, J =7.0 Hz, H-7), 2.68 (2H, t, J =7.6 Hz, H-2),
2.82 (2H, t, J =7.6 Hz, H-1), 3.86 (3H, s, OCH3), 6.66 (1H,
dd, J =8.0, 2.0 Hz, H-6’), 6.68 (1H, d, J =2.0 Hz, H-2’),
6.83 (1H, d, J =2.0 Hz, H-5), 7.15 ~ 7.20 (3H, m, H-3”,
4”, 5”), 7.26 ~ 7.29 (2H, m, H-2”, 6”); 13C-NMR (CDCl3,
125 MHz) δ: 210.3 (C-3), 146.3 (C-3′), 143.8 (C-4′), 142.1
(C-1″), 133.0 (C-1′), 128.2 (c-2″, 6″), 128.3 (C-3″, 5″),
125.7 (C-4″), 120.7 (C-6′), 114.3 (C-5′), 111.0 (C-2′), 55.8(OCH3), 44.6 (C-2), 42.9 (C-4), 35.7 (C-7), 30.9 (C-6), 29.5
(C-1), 23.3 (C-5). These data were compared with litera-
ture values [25]. The chemical structure of yakuchinone A
was shown in Figure 1A. The purity of yakuchinone A is
99.2%. The solubility of yakuchinone A was 100 mM in
dimethylsulfoxide (DMSO).
Assay for free radical scavenging ability against
DPPH· and ABTS+
The radical scavenging activities of yakuchinone A
against DPPH · and ABTS · + radicals were measured by
using the method as previously reported [26]. For
DPPH · radical scavenging activity analysis, 5, 10, 20, 30,
40, 50, and 100 μM yakuchinone A (10 μl of solution)
was mixed with 90 μl of DMSO and 900 μl of ethanolic
DPPH · solution (0.1 mM). After incubation in darkness
at 25°C for 30 min, the absorbance (A) was determined
at 517 nm (Hitachi U-2001, Japan). For ABTS•+ radical
scavenging activity analysis, ABTS · + was dissolve in
water to 7 mM. ABTS · + radical was produced by
reacting ABTS · + stock solution with 2.45 mM potas-
sium persulfate, and the mixture stood in the dark at
room temperature for 12–16 h. The ABTS · + radical so-
lution was diluted to an absorbance of 0.70 ± 0.02 at
734 nm at 30°C. Each agent (0.1 ml) reacted with 2.9 ml
of diluted ABTS · + radical solution for 20 min at 30°C,
and then the absorbance was measured at 734 nm
(Hitachi U-2001, Japan). The TEAC (trolox equivalent
antioxidant capacity) of the reagent was calculated by
comparing their reactivities to the standard antioxidant,
trolox. Ethanol or distilled water was used as negative
controls. Trolox was used as a standard antioxidant. The
scavenging ability of yakuchinone A or trolox in DPPH ·
and ABTS · + was calculated using the following equation:
radical scavengingability (%) = (1 −Asample/Acontrol) × 100.
EC50 values were estimated from the percent inhibition
versus concentration plot derived from the percentage
scavenging activity. This data was shown as mean
values ± standard deviation (n = 3).
Determination of antioxidant effect on liposome
peroxidation
The effect on liposome peroxidation was assayed by
measuring concentrations of thiobarbituric acid reactive
substances (TBARS). Liposomes were prepared according
to the method of Chou et al. [27]. In brief, the liposomes
were obtained by dispersing lipids in demineralized water
(1:10). For the assay, 32 μl of suspension of liposomes was
incubated together with 11 μl of 10 mM FeSO4, 11 μl of
10 mM ascorbic acid and appropriate amounts of different
concentrations (5, 10, 20, 30, 40, 50 and 100 μM) of
yakuchinone A, trolox and rutin in 1.515 ml of 50 mM
Na2HPO4-NaH2PO4 buffer, pH 7.4 (2.5 ml final solution)


































































































































































Figure 1 Antioxidant activity of yakuchinone A. A) Chemical structure of yakuchinone A from Alpinia oxyphylla Miq. M.W. = 312. B) DPPH · and
C) ABTS · + free radical scavenging activities of yakuchinone A and trolox (5, 10, 20, 30, 40, 50, and 100 μM). D) Inhibition of lipid peroxidation by
yakuchinone A, trolox, and rutin (5, 10, 20, 30, 40, 50, and 100 μM) using liposome as an oxidizable substrate. Data are presented as mean ± SD from
three independent experiments; *p < 0.05 indicates significant difference from vehicle-treated cells. Yakuchinone A; YA.
Lin et al. BMC Complementary and Alternative Medicine 2013, 13:237 Page 4 of 13
http://www.biomedcentral.com/1472-6882/13/237reaction of 0.8 ml of 1% TBA and 10% TCA and 106 μl
of 0.1 M ethylene diamine-tetraacetic acid disodium
salt dehydrate at 100°C for 20 min. After cooling and
centrifugation (2600 g for 10 min), the malonaldehyde
(MDA)-TBA complex was determined by measuring
the absorbance (A) at 532 nm. A control with DMSO
instead of sample was also analyzed and expressed no
activity. Trolox and rutin were utilized as standards.
The percentage inhibition was calculated using the fol-
lowing equation: Inhinition of lipid peroxidation (%) =
(1 − Asample/Acontrol) × 100. EC50 values were estimated
from the percentage inhibition versus concentration
plot. This data was shown as mean values ± standard
deviation (n = 3).Cell lines
Human epidermoid carcinoma A431, human oral squa-
mous cell carcinoma SCC25. human skin malignant mel-
anoma A375, mouse melanoma B16, mouse leukemic
monocyte macrophage RAW 264.7, mouse normal em-
bryonic liver BNLCL2 cells, and 3 T3-L1 preadipocytes
were purchased from the American Type Culture Col-
lection (Rockville, MD). Human basal cell carcinoma
BCC and human premalignant keratinocytic HaCaT
cells were kindly donated by Prof. Hamm-Ming Sheu
(National Cheng Kung University Medical College, Tainan,
Taiwan). Cells were cultured in medium supplemented
with 10% fetal bovine serum (Hazelton Product, Denver,
PA) and 1% penicillin-streptomycin at 37°C in 5% CO2
Lin et al. BMC Complementary and Alternative Medicine 2013, 13:237 Page 5 of 13
http://www.biomedcentral.com/1472-6882/13/237humidified atmosphere; specifically, A431, A375, B16,
HaCaT, RAW 264.7, BNLCL2, and 3 T3-L1 cells were
maintained in DMEM medium (GIBCO, Grand Island,
NY), BCC cells in RPMI medium, and SCC25 in DMEM/
F12 medium supplemented with 0.4 μg/ml hydrocortisone
(Sigma, St. Louis, MO).
Adipocyte differentiation
Cultivation of 3 T3-L1 cells and their conversion to adi-
pocytes were carried out according to the method as de-
scribed previously [28]. To induce differentiation, four
day postconfluent 3 T3-L1 preadipocytes were stimu-
lated for 72 h in 10% FBS/DMEM with containing the
MDI hormone mixture (0.5 mM IBMX, 1 μM dexa-
methasone, and 10 μg/ml of insulin) in six-well plates.
After four days, the medium was replaced with 10%
FBS/DMEM medium containing 10 μg/ml of insulin.
The medium was replaced with fresh medium (10%
FBS/DMEM, 10 μg/ml of insulin) every two days until
analysis on day eight. Yakuchinone A (5 μM) was added
during the differentiation process.
Oil Red O staining
Differentiated 3 T3-L1 cells were stained using the Oil Red
O method [29] for adipocyte lipid accumulation. At day
eight of differentiation, the cells were washed with PBS and
fixed with 10% formaldehyde for 2 h. The fixed cells were
washed with 60% isopropanol, and stained with 0.2% Oil
Red O for 10 min. The plates were rinsed three times with
water and examined under a phase contrast inverted light
microscope (Nikon, TE2000-U, Japan). After thorough
washing with water and evaporation of excess water, Oil
Red O was extracted in isopropyl alcohol and the absorb-
ance was monitored at 520 nm (BioTek, Synergy™2).
Cell viability
Cells (1 × 105 cells/ml) were plated in 100 μl of 96-well
multidishes and treated with a series of concentrations
(5, 10, 20, 30, 40, and 50 μM) of yakuchinone A or ve-
hicle control (DMSO) for 72 h. The control groups were
treated with DMSO, and the final DMSO concentration
did not exceed 0.1%. The cell viability was measured by
performing the MTT [3-(4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyl-tetrazolium bromide] assay [30]. The IC50
values were calculated from the agent concentrations
that yielded a cell viability of 50%.
Cell morphological changes
Cells (1 × 105 cells/ml) were plated in 24-well plates then
treated with vehicle control (DMSO) or yakuchinone A
(20 μM) for 72 h. Cells in each well were washed once
with 1× PBS, and analysis was performed using a phase
contrast inverted light microscope (Nikon, TE2000-U,
Japan). To assess specific apoptosis, after incubation, cellswere washed by PBS and fixed with 4% paraformaldehyde
and stained with Hoechst 33342 (0.1 μg/ml) (Sigma) at 37°C
for 10 min in the dark. The nuclear morphology
changes were viewed under a fluorescent microscope
(Nikon, TE2000-U, Japan).
RNA isolation and reverse transcription-polymerase chain
reaction (RT-PCR) analysis
3 T3-L1 cells were treated with vehicle control (DMSO)
or yakuchinone A (5 μM) during the differentiation
process. BCC cells (1 × 105 cells/ml) were treated with ve-
hicle control (DMSO) or yakuchinone A (20 μM) for 24
and 48 h. Total RNA was prepared from cells using the
Trizol reagent (Invitrogen, Carlsbad, CA, USA), and a RT-
PCR was conducted using 3 μg of total RNA and the
Superscript cDNA Preamplification System (Weiterstadt,
Germany) according to the manufacturers’ instructions.
The following primers were utilized: right primer 5′-GCT
CTA GAC GTG ACA ATC TGT CTG AGG TCT GTC
AT-3′ and left primer 5′-CGG CAT CCG TTG TCG
GTT TCA CAA ATG CCT TGC AGT G-3′ for PPAR γ
(870 bp), right primer 5′-CAT CTG CTG GCC TTC
TCC AA-3′ and left primer 5′-ATC CAG GCT CTC
TGG CTT CTG-3′ for leptin (71 bp), right primer 5′-
AGA TGT CCA GCC AGC TGC ACC TGA C-3′ and
left primer 5′-AGA TAG GCA CCC AGG GTG ATG
CAA GCT-3′ for bcl-2 (367 bp), right primer 5′-AAG
CTG AGC GAG TGT CTC AAG CGC-3′ and left primer
5′-TCC CGC CAC AAA GAT GGT CAC G-3′ for bax
(366 bp), and right primer 5′-ACC CAC ACT GTG CCC
ATC TA-3′ and left primer 5′-CGG AAC CGC TCA
TTG CC-3′ for β-actin (286 bp). The amplified RT-PCR
products were analysed in 2% agarose gels, visualized by
ethidium bromide staining and photographed under ultra-
violet light.
Western blotting
Cells (1 × 105 cells/ml) were treated with vehicle con-
trol (DMSO) or yakuchinone A (20 μM) for 72 h.
Then, cells were washed with PBS, and lysed in lysis
buffer [50 mM Tris–HCl, pH 7.5, 1% Triton X-100,
5 mM EGTA (ethylene glycol-bis(2-aminoethylether)-
N,N,N’,N’-tetraacetic acid), 150 mM NaCl and 1 mM
phenylmethylsulfonyl fluoride (PMSF)]. After centrifuga-
tion (10,000 g, 10 min), supernatants were collected. The
cell lysates containing 40 μg of solubilized protein were
subjected to 12% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and electrophoretically
transferred to nitrocellulose membranes. The membranes
were blocked in 5% skim milk. Blots were incubated with
the antibodies against Bcl-2, Bax, PARP and β-actin (Santa
Cruz, CA). The membranes were incubated with the ap-
propriate secondary antibody conjugated with horseradish
peroxidase (Bio-Rad, Hercules, CA). Blotted antibodies
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Preparation of H. nana adult worms
H. nana adult worms were obtained from each part of
the intestines of wild type mice, purchased from Lin’s
farm in Fengshan, Kaohsiung, Taiwan. These parts of the
intestine were duodenum, jejunum, ileum, colon and
rectum. The H. nana had an average length of 5–50 mm
and was collected using a needle with a blunt tip, before
being placed in Petri dishes with 0.9% NaCl and
gentamycin (10 mg/ml). They were then washed several
times. The adult worms were individually observed under
an inverted microscope, with subsequent discarding of
those that exhibited internal or external damage. The
adult worms were then identified by their morphological
features, divided into groups and placed in 24-well plates
contained cultivated media RPMI-1640 plus 20% FBS,
pH 7.4, in an atmosphere of 95% O2/5% CO2, 37°C. These
culture conditions have been shown to maximize the de-
velopment and survival of H. nana.
Assay of cestocidal activity of oscillation and peristalsis
test on H. nana
The above H. nana cultivated media were supplemented
with L-glutamine (2 mM), penicillin (100 IU/ml), strepto-
mycin (100 mg/ml) and amphotericin B (0.25 μg/ml), and
then the effects of yakuchinone A at concentrations of 10,
50 and 100 μM were tested. The survival and mobility of
the adult worm were assessed at 2, 4, 6, 12, 24, 48, and
72 h using a stereomicroscope. They were observed for
their spontaneous motility and evoked responses at 2, 4, 6,
12, 24, 48, and 72 h using a stereomicroscope. The oscilla-
tion and peristalsis states of adult worms were scored
blindly by two investigators. Cestode activity was scored
by monitoring both oscillation and peristalsis. Oscillation
was scored of movement at scolex and neck for each sec-
ond for 30 seconds, and then the highest score was 30.
Peristalsis was record the contraction real times at scolex
and neck. All data were compared with the initial time be-
fore the test compounds had been added. Worms death
and complete standstill as determined by none any oscilla-
tion and peristalsis changes for 30 seconds were identified.
The mortality was recorded after ascertaining that the
worms neither moved when shaken vigorously nor when
dipped in warm medium [31].
A. simplex larvae preparation
The AsL3 were obtained from the muscle and periton-
eum of fresh Trichiurus lepturuss (largehead hairtail, At-
lantic cutlassfish) that were purchased from the fish
market of Kaohsiung, Taiwan. The AsL3 had an average
length of 20–22 mm, and were collected using a needle
with a blunt tip, placed in Petri dishes with 0.9% NaCland washed several times. The majority of the larvae
were encysted, but they quickly became excysted upon
washing in NaCl solution. They were individually ob-
served under an inverted microscope, with subsequent
discarding of those that exhibited internal or external
damage. The larvae were then identified by morpho-
logical features, divided into groups and placed in 24-
well plates contained cultivated media RPMI-1640 plus
20% FBS, pH 4.0, in an atmosphere of 95% O2/5% CO2,
37°C. These showed culture conditions demonstrated to
provide for the maximum development and survival
of A [18,32].
Assay of nematocidal activity on A. simplex
The above AsL3 cultivated media were supplemented with
L-glutamine (2 mM), penicillin (100 IU/ml), streptomycin
(100 mg/ml) and amphotericin B (0.25 μg/ml), and tested
of yakuchinone A for 10, 100, and 200 μM. The survival
and mobility of the larvae were assessed at 2, 4, 8, 12, 24,
48 and 72 h using a stereomicroscope. Two investigators
blindly scored the larvae as dead, with poor mobility or
with normal mobility. The percentage losses of spontan-
eous motion during 3 min periods immediately after incu-
bation and complete standstill were determined by
stimulation 4–5 h later (defined as death). The mortality
was recorded after ascertaining that the worms neither
moved when shaken vigorously nor when dipped in warm
medium. The nematocidal activity was modified according
to a scoring system that was developed by Kiuchi et al.
[33] and Lin et al. [18].
Statistical analysis
The results are expressed as mean ± standard deviation
(SD). Statistical differences were estimated by one-way
analysis of variance (ANOVA) followed by Dunnett’s test
or the Tukey-Kramer test. A p value of 0.05 was
regarded as significant. The data were analyzed and the
figures plotted using software (SigmaPlot Version 8.0
and SigmaStat Version 2.03, Chicago, IL).
Results and discussion
Free radical scavenging activity of yakuchinone A
The DPPH · and ABTS · + radical has been widely used
for assessment of radical scavenging because of the easy
and convenient consideration [34]. The soluble free rad-
ical DPPH · is well known as a good hydrogen abstractor
that yields DPPH-H as a by-product. Thus, the scaven-
ging of DPPH radicals by phenols is effective. The anti-
oxidant activity of yakuchinone A and trolox (a positive
control) was measured based on scavenging activities for
stable DPPH radical as presented in Figure 1B. With in-
creasing doses from 5 to 100 μM of yakuchinone A and
trolox, the values of DPPH · scavenging activity were
9.6%, 29.2%, 34.5%, 44.6%, 60.0%, 64.5%, and 70.7% for
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96.3%, and 97.4% for trolox, respectively. The EC50
values of yakuchinone A for the scavenging of DPPH ·
radicals were 33.5 (yakuchinone A) and 17.9 μM (trolox).
The generation of ABTS · + involves the direct production
of the blue/green ABTS · + chromophore through the re-
action of potassium persulfate and ABTS. The addition of
hydrogen-donating antioxidants to the preformed radical
reduces it to ABTS [35]. Figure 1C shows the scavenging
activity of yakuchinone A towards ABTS · +. As increasing
doses of 5, 10, 20, 30, 40, 50, and 100 μM of yakuchinone
A and trolox, the values of ABTS · + scavenging capacity
were 5.7%, 11.7%, 22.5%, 31.0%, 49.6%, 63.6%, and 70.6%
for yakuchinone A and 21.9%, 27.3%, 47.6%, 49.6%, 75.1%,
92.2%, and 98.0% for trolox, respectively. The EC50
values for the scavenging of ABTS · +-radicals were
40.2 (yakuchinone A) and 30.1 μM (trolox). The extent
of decolorization as percentage inhibition of the ABTS · +
radical cation was proportional to the concentration of an-
tioxidants and calculated relative to the reactivity of trolox
as a standard (TEAC). The TEAC value derived from the
dose–response curve for yakuchinone A was 3.4 mM of
trolox/g. These results suggest that yakuchinone A ex-
hibits an antioxidant capacity to scavenge DPPH · and
ABTS · + free radicals.
Potential of yakuchinone A to inhibit lipid peroxidation
The antioxidant action is assessed by inhibiting the
damage caused by free radicals and the mechanisms
involved in many human diseases such as hepatotoxic-
ities, hepatocarcinogenesis, diabetes, malaria, acute myocar-
dial infarction, and skin cancer to include lipid peroxidation
as a main source of membrane damage [9]. Lipid peroxida-
tion in biological systems has been thought to be a toxico-
logical phenomenon that leads to various pathological
consequences. MDA formed from lipid peroxidation of un-
saturated phospholipid reacts with TBA to produce a pink
MDA-TBA adducts. MDA is reactive and active in cross-
linking with DNA and proteins and damages liver cells [36].
Phospholipids are believed to be present in high amounts in
cell membranes [37]. The phospholipid prepared as a lipo-
some was used to evaluate the effect of yakuchinone A on
liposome peroxidation to investigate yakuchinone A in a
biological system. Figure 1D presents the inhibition of
lipid peroxidation by yakuchinone A (5, 10, 20, 30, 40, 50,
and 100 μM) depended on dose. The EC50 values of the
inhibition of lipid peroxidation efficiency by yakuchinone
A, trolox and rutin were 10.3, 14.3 and 6.2 μM, re-
spectively. Although the inhibition of lipid peroxida-
tion activity by yakuchinone A was weaker than by
rutin, the inhibition efficiency of yakuchinone A exceeded
trolox. The MDA lowering effect of yakuchinone A indi-
cates a protective action against lipid peroxidation of un-
saturated phospholipids.Inhibition of lipid accumulation by yakuchinone A in
3 T3-L1 adipocytes
Numerous studies show that obesity may induce systemic
oxidative stress, and the increase in ROS in adipocytes
contributes to deregulated expression of inflammatory cy-
tokines such as tumor necrosis factor-α, which may be an
early instigator of the obesity-associated diabetes and
cardiovascular disease [37,38]. This work demonstrates
that yakuchinone A exhibits anti-oxidation activities,
suggesting yakuchinone A has an inhibitory effect on
adipogenesis. 3 T3-L1 adipogenic differentiation re-
quires a network of adipogenic markers [3]. We exam-
ined the ability of the yakuchinone A to prevent
adipogenesis in 3 T3-L1 adipocytes. The amount of ac-
cumulated intracellular lipid droplets were compared
in differentiated 3 T3-L1 cells after treatment in a
MDI mixture and differentiated cells. The amount of
intracellular lipid droplets increased in differentiated
3 T3- L1 cells, as shown by the Oil Red O staining
(Figure 2A). However, incubation of differentiated cells
with low concentration of yakuchinone A (5 μM) de-
creased MDI-induced lipid accumulation. This result
was further supported by quantitative spectrophotometric
analysis of cellular neutral lipid content. Figure 2B shows
lipid accumulation was significantly inhibited in the pres-
ence of 5 μM yakuchinone A. The level of lipid accumula-
tion over eight days was 19.2% of the MDI-treated
positive control cells. Adipocytokines are adipocyte-
derived hormones, such as leptin and adiponectin, which
modulated hepatic and peripheral lipid and glucose me-
tabolism [4]. The amount of leptin secreted in the adipose
tissue is positively correlated with the lipid content and
adipocyte size [4]. Furthermore, previous research has
established that adenosine 5′-phosphate-activated protein
kinase (AMPK) and peroxisome proliferator-activated re-
ceptor γ (PPARγ) appears to be involved in adipocyte dif-
ferentiation and maturation. This can be potential drug
targets for the treatment of obesity [3]. We evaluated the
yakuchinone A-induced changes in the expression of adi-
pose tissue genes associated with adipogenesis through
RT-PCR analyses. As shown in Figure 2C, addition of
yakuchinone A (5 μM) suppressed the expression of
leptin and PPARγ significantly as revealed by RT-PCR.
These results suggest that yakuchinone A inhibits and
adipogenesis due in part to the inhibition of angiogen-
esis. These events may be mediated, in part, through
antioxidative properties of yakuchinone A responsible
for inhibition of angiogenesis.
Effect of yakuchinone A on cell viability and skin cancer
cell apoptosis
Previous report have demonstrated that yakuchinone A
exhibits no cytotoxicity against human lung adenocar-
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Figure 2 Yakuchinone A inhibits adipocyte differentiation. A) Photomicrograph of Oil Red O stained differentiating 3 T3-L1 cells. Cells were
treated with yakuchinone A (5 μM) for eight days. Lipid accumulation was measured by Oil Red O staining. B) Percentage lipid accumulation was
analyzed by quantitative analysis of Oil Red O staining. Data are presented as mean ± SD from three independent experiments; *p < 0.05 indicates
significant difference from vehicle-treated cells. C) The gene expressions of leptin, PPARγ, and β-actin were determined by RT-PCR.
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http://www.biomedcentral.com/1472-6882/13/237cells, and human gastric cancer SGC-7901 cells at a con-
centration of 10 μg/ml [39], but yakuchinone A induces
apoptotic death in HL-60 cells [23]. Nevertheless, cyto-
toxic effects of yakuchinone A on skin cancer cells re-
main poorly understood. In this work, the inhibition
potential of yakuchinone A on human skin cancer cells
(epidermoid carcinoma A431 cells, basal cell carcinoma
BCC cells, squamous cell carcinoma SCC25 cells and
malignant melanoma A375 cells) and mouse melanoma
B16 cells was determined by MTT assay and morpho-
logical change. Treatment these cells with yakuchinone
A (5, 10, 20, 30, 40, and 50 μM) for 72 h resulted in a
dose-dependent significant cell death (Figure 3). The
IC50 values of yakuchinone A were 13.3, 11.3, 18.7, 23.8,
and 40.0 μM for A431, BCC, SCC25, A375, and B16
cells, respectively. Moreover, after 72 h treatment with
yakuchinone A (5, 10, 20, 30, 40, and 50 μM), the IC50
values of yakuchinone A against noncancerous cells (hu-
man premalignant keratinocytic HaCaT cells and mouse
embryonic liver BNLCL2 cells) and mouse leukemicmonocyte macrophage RAW 264.7 cells were 22.2, 32.2,
and 46.4 μM, respectively (Figure 4). Yakuchinone A
appeared to have a more potent inhibitory effect on
non-melanoma skin cancer (NMSC) cells (A431, BCC,
and SCC25) and cell viability than in melanoma cells
(A375 and B16), noncancerous cells (HaCaTand BNLCL2),
and RAW 264.7 cells. Previous studies have demonstrated
that yakuchinone A has a phenolic diarylheptanoid
moiety with a carbonyl functional group to suggest
that yakuchinone A is anticipated to exhibit potential
cancer chemopreventive activities [39]. These experi-
mental data further suggest that yakuchinone A has an
antioxidant affect that exhibits less toxic to noncancerous
cells and selective cytotoxicity to NMSC cells.
The cell death induction by yakuchinone A was fur-
ther confirmed by cellular morphological examination.
After exposure of 20 μM yakuchinone A to BCC cells at
72 h, distinct cytoplasmic shrinkage, cell bodies became
rounded and detached from the surface under phase-




















































































































































Figure 3 Effect of yakuchinone A on cell viability in skin cancer cells. Cell viability of yakuchinone A (5, 10, 20, 30, 40, and 50 μM) to skin
cancer (A431, BCC, SCC25, A375, and B16) cells for 72 h, and assessed by MTT assay. Each value is presented as mean ± SD of three individual
experiments; *p < 0.05 indicates a significant difference from vehicle control (DMSO)-treated cells. Yakuchinone A; YA.
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http://www.biomedcentral.com/1472-6882/13/237Treatment of BCC cells with yakuchinone A showed
chromatin condensation and nuclear fragmentation by
Hoechst 33342 staining under a fluorescent microscope,
indicating apoptosis (Figure 5A). Bcl-2 family members
are major apoptosis-regulating proteins [40]. Given that













































Figure 4 Effect of yakuchinone A on cell viability in noncancerous ce
with yakuchinone A (5, 10, 20, 30, 40, and 50 μM) for 72 h. Cell viability wa
three individual experiments; *p < 0.05 indicates a significant difference frommitochondrial functions, expression levels of anti-
apoptotic protein Bcl-2, and pro-apoptotic protein Bax
were determined. Bcl-2 expression was time-dependent
decreased; whereas, bax was increased and investigated
by RT-PCR following the exposure of BCC cells to
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Figure 5 Expression of Bcl-2 and bax-dependent apoptotic pathway in BCC cells after yakuchinone A treatment. A) Morphological
changes induced by yakuchinone A in BCC cells. BCC cells were treated with yakuchinone A (20 μM) and vehicle control (DMSO) for 72 h, and
then the nuclear was stained with Hoechst 33342. Apoptotic cells (arrows) were characterized by cellular shrinkage and rounded cell bodies
(phase-contrast-inverted microscopic, 200×). Under a fluorescent microscope, apoptotic cells (arrows) were characterized by marked nuclear
condensation, shrinking and fragmentation (200×). B) Effect of yakuchinone A on bcl-2 and bax expressions. BCC cells were treated with
yakuchinone A (20 μM) and vehicle control (DMSO) for 24 and 48 h, and the bcl-2, bax and β-actin expressions were determined by RT-PCR.
C) Expressions of Bcl-2, Bax and PARP on cells after yakuchinone A treatment. BCC cells were treated with (+) or without (−) yakuchinone A
(20 μM) for 72 h, and the Bcl-2, Bax, PARP and β-actin expression were assessed by Western blotting.
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yakuchinone A (20 μM) applied for 72 h by Western
blotting (Figure 5C). Cleavage of the poly (ADP-ribose)
polymerase (PARP) in BCC cells after yakuchinone A
treatment gave further evidence that apoptosis happened
because the active form of PARP, a protein associated with
DNA repair, is considered as a hallmark of apoptosis.
These results suggest that yakuchinone A-induced cell
death is mainly due to apoptosis.
Cestocidal activity against H. nana
Figure 6 plots the time course of oscillation and peristal-
sis during yakuchinone A treatment. In oscillation activ-
ity assay, the percentage of oscillation for the vehicle
control (0.1% DMSO) decreased by about 18% from
72 h cultivation (Figure 6A). However, in the peristalsis
activity assay, the percentage of peristalsis for the vehicle
control (0.1% DMSO) decreased by 31% from 72 h culti-
vation (Figure 6B). The change of peristalsis of H. nana
was more sensitive than that of oscillation via treatment of
vehicle. Treatment with 10, 50, and 100 μM yakuchinone
A has a greater effect on peristalsis than oscillation for 24,
48, and 72 h. Peristalsis activity disappeared before oscilla-
tion activity was lost when H. nana was dead. In fact, H.
nana has no peristalsis or oscillation effect when dead.
In the oscillation activity assay (Figure 6A), exposure
to 100 μM yakuchinone A for 72 h caused the maximumeffect of 27% of H. nana. Treatment with yakuchinone A
(a concentration of 50, 100 μM but not 10 μM) for 48
and 72 h reduced the oscillation up to 21% and 31% or
47% and 73%, respectively. Yakuchinone A slowly re-
duced oscillation from 2 to 72 h but did not cause
death. Yakuchinone A reduced the oscillation activity
of H. nana in a time- and dose-dependent manner for
24 to 72 h (Figure 6A).
The effect of yakuchinone A over time of the peristal-
sis activity of H. nana was investigated (Figure 6B). For
peristalsis activity assay, a dose- and time-dependent ef-
fect for 24 to 72 h was also observed by treatment with
yakuchinone A. Treatment for 48 h with 50 and 100 μM
yakuchinone A stopped peristalsis in more than approxi-
mately 21 to 25% of worms. Yakuchinone A at 50 and
100 μM slowly reduced peristalsis from 2 to 72 h. Treat-
ment with 10 μM yakuchinone A for 72 h reduced peri-
stalsis to 22% (Figure 6B). This effect on peristalsis is
stronger than on oscillation activity. The above perfor-
mances were the same for other concentrations of
yakuchinone A in peristalsis activity.
Nematocidal activity against A. simplex
In the first series of experiments, the larvicidal effects
were used to study the ability of yakuchinone A to alter
survival of AsL3. The time course of the yakuchinone
A-induced loss of mobility on AsL3 was also studied.
Time (h)


















































































Figure 6 Effect of yakuchinone A on H. nana. Treatment with various concentrations of yakuchinone A (10, 50, and 100 μM) with incubation
times of 2, 4, 6, 12, 24, 48, and 72 h on H. nana, respectively. Time course of effect on oscillation A) and peristalsis B) of H. nana of yakuchinone
A presented as percentages. Vehicle is 0.1% DMSO solvent. Each value is presented as mean ± SD of three individual experiments; *p < 0.05
indicates a significant difference from the result for vehicle-treated worms.
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http://www.biomedcentral.com/1472-6882/13/237Figure 7A shows more than 20% of the worms had
stopped moving at 72 h of treatment with 10, 100 and
200 μM yakuchinone A, whereas up to 10% of the lar-
vae ceased movement activity at 12 h of treatment with
200 μM. Additionally, the maximum loss of spontaneous
movement occurred at a concentration of 200 μM.
Yakuchinone A caused a dose- and time-dependent
loss of spontaneous movement. However, the vehicle
(0.1% DMSO) had no effect on AsL3. Approximately,
up to 20% of the larvae were dead at 48 h at 10, 100
and 200 μM yakuchinone A (Figure 7B), and up to 35%Time (h)
































Figure 7 Time course of larvicidal activity A) and loss of spontaneous
of yakuchinone A (10, 100, and 200 μM) for 2, 4, 8, 12, 24, 48 and 72 h on t
value is presented as mean ± SD of three individual experiments. Statistical
for vehicle-treated worms.and 40% of the larvae were dead at 48 and 72 h, re-
spectively, including 100 and 200 μM. Figure 7B shows
A. simplex mortality was observed to be up 40% at
48 h after exposure to 100 and 200 μM yakuchinone
A, which showed more lethal efficacy than against H.
nana (Figure 6).
Conclusions
Yakuchinone A isolated from A. oxyphylla scavenges
radicals of biological interest and preventes damage to
oxidative stress. The study suggests that yakuchinone ATime (h)







































movements B) of A. simplex by yakuchinone A treatment. Effect
hird-stage larvae of A. simplex. Vehicle is 0.1% DMSO solvent. Each
ly significant, *p < 0.05 indicates a significant difference from the result
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with yakuchinone A reduces the intracellular accumulation
of neutral lipids and suppresses the induction of leptin and
PPARγ. Moreover, theses experimental results suggest that
inhibition of cell growth by yakuchinone A is more signifi-
cant for NMSC than for melanoma and noncancerous cells.
Following incubation with yakuchinone A in BCC cells in-
creases apoptotic body formation as well as down-regulated
Bcl-2, up-regulated Bax, and increased cleavage PARP. Add-
itionally, previous studies have shown that yakuchinone A
has a stronger nematocidal activity of A. simplex than
cestocidal activity of H. nana. These results support the de-
velopment of selective and efficient natural anthelmintic
compounds against helmineth or cestode (Additional file 1).
Previous evidence has established that larvicide activity to-
ward A. simplex does not depend on scavenging activity,
and that free radicals can be harmful to A. simplex, for
which the scavenging of these free radicals permits larvae to
survive. However, this report is the first to verify that
yakuchinone A has the cestocidal activity against H. nana,
the scavenging activity against DPPH · and ABTS · + radi-
cals, and the elimination effect on the spontaneous move-
ment of AsL3. Therefore, the radical scavenging activity of
yakuchinone A does not reduce its ability to stop the
spontaneous movement of AsL3 or its cestocidal activity
on H. nana. Further investigations must be conducted to
elucidate the anthelmintic mechanisms of yakuchinone A
against A. simplex and H. nana as well as its ability to
eliminate the spontaneous movement of A. simplex and
H. nana including their relationships to free radical scav-
enging activities.Additional file
Additional file 1: Yakuchinone A exhibits antioxidative properties,
anti-adipocyte differentiation, antitumor activity, and anthelmintic
activities against A. simplex and H. nana.Abbreviations
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